Back to Screener

Healthcare

Checkpoint Therapeutics, Inc.(CKPT)

Live Price

Offline

$4.26

+0.00% today

1Y Change

Window

No data

Market Cap
$367.72M
Revenue Growth
-60.2%
EPS Growth
+48.7%
Dividend Yield
0.0%
No coverage

Historical coverage is still loading

We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.

No price data

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Checkpoint Therapeutics, Inc. (CKPT) is a Healthcare stock with a market cap of $367.72M. The stock last traded around $4.26. Baseline metrics include revenue growth of -60.2%, EPS growth of +48.7%, a dividend yield of 0.0%. What stands out right now is revenue -60.2%, EPS +48.7%, free cash flow +34.6% with operating margin 0.0% and ROIC -245.3%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CKPT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

-60.2% vs +7.6% peer median

Operating Margin

Below sector median

0.0% vs +19.4% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 11, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at -60.2% and EPS is at +48.7%, with operating margin around 0.0%.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

CKPT

Normalized return

SPY

S&P 500

Excess Return

Relative to SPY

CKPT Max Drawdown

Trailing 1Y

SPY Max Drawdown

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CKPT and SPY.

Calendar-year return history is still loading or unavailable.
CH

Company Overview

Checkpoint Therapeutics, Inc.

Last Updated
May 8, 2026

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
EV/EBITDA
Price/Sales
Price/Book
0.2

Growth

Revenue
-60.2%
EPS
+48.7%
Free Cash Flow
+34.6%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-2185.9%
ROIC
-245.3%

Balance Sheet

Debt/Equity
Current Ratio
1.91

Earnings Reports

📅 Last reportedMay 11, 2026
PeriodB/MEPSEPS ΔRevenueRev Δ
May 11, 26
Est
Est
Nov 10, 25
Est
Est
Aug 11, 25
Est -0.02
Est 7283.0B
May 13, 25
-0.19
Est -0.17
-11.8%
Est 4531.0B
Mar 28, 25
-0.69
Est -0.22
-213.6%
Est
Nov 12, 24
-0.23
Est -0.15
-53.3%
Est 10.3B
Aug 12, 24
-0.18
Est -0.29
+37.9%
41.0B
Est 20.0B
+105.0%
May 10, 24
-0.33
Est -0.37
+10.8%
Est 10.0B
Mar 22, 24
-1.10
Est -0.74
-48.6%
6.0B
Est 20.0B
-70.0%
Nov 13, 23
-0.29
Est -0.85
+65.9%
31.0B
Est 20.0B
+55.0%
Aug 14, 23
-1.05
Est -0.83
-26.5%
31.0B
Est 10.0B
+210.0%
May 15, 23
-0.89
Est -0.92
+3.3%
35.0B
Est 20.0B
+75.0%
Mar 31, 23
-2.29
Est -1.31
-74.8%
74.0B
Est 30.0B
+146.7%
Nov 8, 22
-1.20
Est -1.70
+29.4%
48.0B
Est 23.3B
+105.7%
Aug 12, 22
-1.60
Est -1.70
+5.9%
18.0B
Est 17.5B
+2.9%
May 12, 22
-2.00
Est -1.10
-81.8%
52.0B
Est 23.3B
+122.9%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.